Holen Sie sich die Stockscreener-App
1.10
1.79%
-0.02
Vorhandelsmarkt:
1.03
-0.07
-6.36%
Schlusskurs vom Vortag:
$1.12
Offen:
$1.12
24-Stunden-Volumen:
908.41K
Relative Volume:
1.10
Marktkapitalisierung:
$93.25M
Einnahmen:
$153.73M
Nettoeinkommen (Verlust:
$-106.79M
KGV:
-0.618
EPS:
-1.78
Netto-Cashflow:
$-115.93M
1W Leistung:
-5.17%
1M Leistung:
+21.08%
6M Leistung:
+0.00%
1J Leistung:
-69.01%
1-Tages-Spanne:
$1.01
$1.12
1-Wochen-Bereich:
$1.01
$1.205
52-Wochen-Spanne:
$0.5231
$4.60
Sutro Biopharma Inc Stock (STRO) Company Profile
Firmenname
Sutro Biopharma Inc
Sektor
Branche
Telefon
650-392-8412
Adresse
111 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA
Vergleichen Sie STRO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
STRO
Sutro Biopharma Inc
|
1.10 | 94.95M | 153.73M | -106.79M | -115.93M | -1.78 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Sutro Biopharma Inc Stock (STRO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-16 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2025-03-17 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2025-03-14 | Herabstufung | BofA Securities | Buy → Underperform |
| 2025-03-14 | Herabstufung | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2025-03-14 | Herabstufung | Wedbush | Outperform → Neutral |
| 2024-05-08 | Eingeleitet | BofA Securities | Buy |
| 2023-11-09 | Eingeleitet | Deutsche Bank | Buy |
| 2023-10-06 | Eingeleitet | Oppenheimer | Outperform |
| 2023-03-21 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-08-18 | Fortgesetzt | Wells Fargo | Overweight |
| 2021-06-18 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-12-03 | Eingeleitet | Stifel | Buy |
| 2020-09-02 | Eingeleitet | Jefferies | Buy |
| 2020-07-16 | Eingeleitet | Wells Fargo | Overweight |
| 2020-01-13 | Eingeleitet | SunTrust | Buy |
| 2019-10-07 | Eingeleitet | BTIG Research | Buy |
| 2019-07-18 | Eingeleitet | Deutsche Bank | Buy |
| 2019-04-29 | Eingeleitet | H.C. Wainwright | Buy |
| 2018-10-22 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2018-10-22 | Eingeleitet | Piper Jaffray | Overweight |
| 2018-10-22 | Eingeleitet | Wedbush | Outperform |
Alle ansehen
Sutro Biopharma Inc Aktie (STRO) Neueste Nachrichten
Applying big data sentiment scoring on Sutro Biopharma Inc.Market Movers & Advanced Swing Trade Entry Plans - newser.com
Can technical indicators confirm Sutro Biopharma Inc.’s reversalTrade Volume Summary & Growth Focused Stock Reports - newser.com
What earnings margins imply for Sutro Biopharma Inc. (S09) stockWeekly Profit Report & AI Powered Buy/Sell Recommendations - newser.com
Statistical indicators supporting Sutro Biopharma Inc.’s strengthBond Market & AI Powered Market Trend Analysis - newser.com
Sutro Biopharma Announces Participation at the 16th Annual World ADC Conference - The Manila Times
Sutro Biopharma, Inc. to Present Innovative Preclinical Data at World ADC Conference 2025 - Quiver Quantitative
Sutro (NASDAQ: STRO) to present preclinical data on dual-payload ADCs at World ADC - Stock Titan
What candlestick patterns are forming on Sutro Biopharma Inc.Jobs Report & High Return Trade Guides - newser.com
Analyzing Sutro Biopharma Inc. with risk reward ratio chartsMarket Performance Summary & Long-Term Capital Growth Strategies - newser.com
Can Sutro Biopharma Inc. recover in the next quarterGap Down & Comprehensive Market Scan Insights - newser.com
Is it too late to sell Sutro Biopharma Inc.Weekly Trading Summary & Real-Time Volume Analysis - newser.com
Published on: 2025-11-02 22:36:42 - newser.com
Is Sutro Biopharma Inc. stock a safe haven assetDollar Strength & Daily Profit Focused Screening - newser.com
Is Sutro Biopharma Inc. stock a buy on dipsDividend Hike & AI Enhanced Trade Execution Alerts - newser.com
Can Sutro Biopharma Inc. (S09) stock deliver strong annual returnsWeekly Trade Review & High Conviction Buy Zone Alerts - newser.com
Applying Wyckoff theory to Sutro Biopharma Inc. stockDividend Hike & Smart Money Movement Alerts - newser.com
Published on: 2025-11-01 09:13:17 - newser.com
Volatility clustering patterns for Sutro Biopharma Inc.Index Update & Long-Term Growth Plans - newser.com
How to monitor Sutro Biopharma Inc. with trend dashboards2025 Valuation Update & Precise Buy Zone Tips - newser.com
How buybacks impact Sutro Biopharma Inc. stock valuePortfolio Update Report & Technical Confirmation Alerts - newser.com
Can Sutro Biopharma Inc. stock sustain revenue growthMarket Performance Recap & Smart Swing Trading Alerts - newser.com
Does Sutro Biopharma Inc. show high probability of rebound2025 Trade Ideas & Reliable Intraday Trade Alerts - newser.com
Identifying reversal signals in Sutro Biopharma Inc.Market Performance Recap & Real-Time Sentiment Analysis - newser.com
Why Sutro Biopharma Inc. stock is considered a top pick2025 Earnings Surprises & Technical Pattern Recognition Alerts - newser.com
Finanzdaten der Sutro Biopharma Inc-Aktie (STRO)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):